MarketBeat is most often covered alongside Weiss Ratings, which appears in 2 of these 4 stories. Across a 35-day span, the pace is roughly 0.8 stories per week. The busiest single day carried 2. Each story carries 1.8 original sources on average, compared with 3.5 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about MarketBeat
MarketBeat is most often covered alongside Weiss Ratings, which appears in 2 of these 4 stories. Across a 35-day span, the pace is roughly 0.8 stories per week. The busiest single day carried 2. Each story carries 1.8 original sources on average, compared with 3.5 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6 for that window. medical-devices accounts for 2 of the 4 tracked stories, while 2 other categories carry the remainder. This profile follows 4 Healthcare stories mentioning MarketBeat across the period from July 10, 2026 to August 13, 2026.
Stories tracked
4
Per week
0.8
Sources per story
1.8
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 351 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering MarketBeat. Shared-story counts are live from our verified record — not editorial picks.
For healthcare and medical device stakeholders, Apyx Medical's Q1 revenue of $12.49 million beat consensus by $1.96 million, yet the stock fell 1.8% to $4.38. The decline on 60% below-average volume suggests limited conviction, while analysts maintain a moderate buy rating and $6.50 target. The company's strong liquidity ratios contrast with its negative net margin and return on equity.
A head-to-head survey gives Weave Communications a stronger rating and 27.58% upside over Surgical Science Sweden, but the two health companies serve very different markets: patient engagement software versus surgical simulation.
MarketBeat's June 21 screener flags Garmin, Life Time, Planet Fitness, Peloton, and Xponential Fitness as the fitness stocks with the highest dollar trading volume. The list spans wearables, gym chains, and connected fitness, all relevant to consumer health and preventive care.
Analyst downgrades reflect growing fears that GLP-1 weight loss drugs could erode the sleep apnea device market, even as ResMed’s financials stay solid. The contrast between a $225 low target and $321 high target underscores sector uncertainty.
MarketBeat is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.